Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up

• Main Authors: Yong Hoon Kim (Author), Ae-Young Her (Author), Seung-Woon Rha (Author), Byoung Geol Choi (Author), Se Yeon Choi (Author), Jae Kyeong Byun (Author), Yoonjee Park (Author), Dong Oh Kang (Author), Won Young Jang (Author), Woohyeun Kim (Author), Cheol Ung Choi (Author), Chang Gyu Park (Author), Hong Seog Seo (Author)
• Format: Book
• Published: Ubiquity Press, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Endeavor®-zotarolimus-eluting stent (E-ZES) was the first ZES to be developed, and Resolute integrity®-ZES (I-ZES) has been developed more recently. Comparative studies on long-term usage of these two ZESs have been rare. Objectives: The aim of this study was to compare the efficacy and...